(1-(Methylsulfonyl)piperidin-4-yl)methanamine hydrochloride
97%
- Product Code: 131409
CAS:
851308-25-3
| Molecular Weight: | 228.74 g./mol | Molecular Formula: | C₇H₁₇ClN₂O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD18378123 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, light-proof, inert gas |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of central nervous system agents. Its structure supports the design of molecules targeting neurological disorders due to the presence of both amine and sulfone functionalities, which can enhance binding selectivity and metabolic stability. Commonly employed in medicinal chemistry for constructing drug candidates with improved pharmacokinetic profiles.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $276.01 |
+
-
|
| 0.250 | 10-20 days | $468.23 |
+
-
|
(1-(Methylsulfonyl)piperidin-4-yl)methanamine hydrochloride
Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of central nervous system agents. Its structure supports the design of molecules targeting neurological disorders due to the presence of both amine and sulfone functionalities, which can enhance binding selectivity and metabolic stability. Commonly employed in medicinal chemistry for constructing drug candidates with improved pharmacokinetic profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :